Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Radenkovic, Dina, Reason, and Eric Verdin
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Presented for research literature review only Takahashi N et al
As a result, it may provide benefits for individuals with brain disorders and memory loss
Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases
US$ 25.84
US$ 21.75
